N.D. Admin Code 33-44-01-48 - Standards for microbiological contaminants and mycotoxin compliance testing
1. Usable marijuana
required to be tested for microbiological contaminants under sections
33-44-01-42, 33-44-01-43, and 33-44-01-44 must be sampled using appropriate
aseptic techniques.
2. For purposes
of the microbiological test, a usable marijuana sample is deemed to have passed
if it meets the following standards for microbial and fungal limits in colony
forming units per gram (CFU/g):
Concentrates |
Medical Cannabinoid Products |
|
Total viable aerobic bacteria |
104 CFU/g |
105 CFU/g |
Total yeast and mold |
103 CFU/g |
104 CFU/g |
Total coliforms |
102 CFU/g |
103 CFU/g |
Bile-tolerant gram-negative bacteria |
102 CFU/g |
103 C FU/g |
Escherichia coli (pathogenic strains) and salmonella species |
Not detected in one gram |
Not detected in one gram |
3.
For purposes of the mycotoxin test, a usable marijuana sample is deemed to have
passed if it meets the following standards:
a.
The total of aflatoxin B1, B2, G1, and G2 is less than 20 µg/kg of
substance; and
b. Ochratoxin A is
less than 20 µg/kg of substance.
4. If the samples do not pass testing
standards for microbiological contaminants or mycotoxins, the manufacturing
facility shall comply with section 33-44-01-52.
Notes
General Authority: NDCC 19-24.1-36
Law Implemented: NDCC 19-24.1-36
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.